✦ LIBER ✦

Molecular mechanisms of resistance and toxicity associated with platinating agents

✍ Scribed by Cara A. Rabik; M. Eileen Dolan

Book ID: 116395089
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 348 KB
Volume: 33
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2006.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance mechanisms associated with al

Resistance mechanisms associated with altered intracellular distribution of anticancer agents

✍ Annette K. Larsen; Alexandre E. Escargueil; Andrzej Skladanowski 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Molecular mechanisms of insulin resistan

Molecular mechanisms of insulin resistance and associated diseases

✍ Barbara Mlinar; Janja Marc; Andrej Janež; Marija Pfeifer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Old and New Molecular Mechanisms Associa

Old and New Molecular Mechanisms Associated with Platelet Resistance to Antithrombotics

✍ Antonio J. López Farré; Juan Tamargo; Petra J. Mateos-Cáceres; Luís Azcona; Carl 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 314 KB

Resistance of Candida species to antifun

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

✍ Dominique Sanglard; Frank C Odds 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 542 KB

Differential protein expression of hepat

Differential protein expression of hepatic cells associated with MeHg exposure: deepening into the molecular mechanisms of toxicity

✍ Cuello, Susana; Ramos, Sonia; Madrid, Yolanda; Luque-Garcia, Jose L.; Cámara, Ca 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 378 KB

Hyperaminoaciduria identifies patients a

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens

✍ Caron, Hubert N. ;Abeling, Nico ;van Gennip, Albert ;de Kraker, Jan ;Voucte, P. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

## Abstract We monitored renal tubular function in 18 neuroblastoma patients treated with chemotherapeutic regimens containing Ifosfamide and platinates. The total IFO dose ranged from 30 to 48 g/m^2^. After each IFO course and at regular intervals during follow‐up 24 hour urinary excretion of amin